Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B R Binder

Showing results (51-60 of 219) with videos related to

Pageof 22
Sort By:
Journal of Vascular Research|July 1, 1997
Regulation of the fibrinolytic potential of cultured human umbilical vein endothelial cells: astragaloside IV downregulates plasminogen activator inhibitor-1 and upregulates tissue-type plasminogen activator expressionW J Zhang, J Wojta, B R Binder
Haemostasis|January 1, 1988
Effect of anti plasminogen monoclonal antibodies on whole blood clot lysisF Ehrenreich, E Hattey, J Wojta, et al.
Urologia Internationalis|January 1, 1983
Effects of external renal hypothermia on postischemic hemodynamicsO Zechner, H Pflüger, M Maier, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1990
Matrix-bound plasminogen activator inhibitor type 1 inhibits the invasion of human monocytes into interstitial tissueJ C Kirchheimer, B R Binder, H G Remold
Advances in Experimental Medicine and Biology|January 1, 1989
Characterization of kinins released from human kininogens by human urinary kallikreinM Maier, G Reissert, I Jerabek, et al.
Thrombosis and Haemostasis|December 22, 1999
Mechanisms of signaling through urokinase receptor and the cellular responseY Koshelnick, M Ehart, H Stockinger, et al.
Blood|July 6, 2000
In vivo inhibition of low density lipoprotein receptor-related protein improves survival of factor VIII in the absence of von Willebrand factorP L Turecek, H P Schwarz, B R Binder
Thrombosis Research|September 1, 1994
Fibrinolytic system of cultured rabbit aortic endothelial cellsD B al-Azhary, J Wojta, B R Binder
European Urology|January 1, 1984
Tissue plasminogen activator activity in prostatic cancerA Köller, J Kirchheimer, H Pflüger, et al.
Immunopharmacology|June 1, 1997
Protein C inhibitor (PCI) and heparin cofactor II (HCII): possible alternative roles of these heparin-binding serpins outside the hemostatic systemM Geiger, M Krebs, I Jerabek, et al.
Pageof 22

Showing results (51-60 of 219) with videos related to

Sort By:
Pageof 22
Journal of Vascular Research|July 1, 1997
Regulation of the fibrinolytic potential of cultured human umbilical vein endothelial cells: astragaloside IV downregulates plasminogen activator inhibitor-1 and upregulates tissue-type plasminogen activator expressionW J Zhang, J Wojta, B R Binder
Haemostasis|January 1, 1988
Effect of anti plasminogen monoclonal antibodies on whole blood clot lysisF Ehrenreich, E Hattey, J Wojta, et al.
Urologia Internationalis|January 1, 1983
Effects of external renal hypothermia on postischemic hemodynamicsO Zechner, H Pflüger, M Maier, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1990
Matrix-bound plasminogen activator inhibitor type 1 inhibits the invasion of human monocytes into interstitial tissueJ C Kirchheimer, B R Binder, H G Remold
Advances in Experimental Medicine and Biology|January 1, 1989
Characterization of kinins released from human kininogens by human urinary kallikreinM Maier, G Reissert, I Jerabek, et al.
Thrombosis and Haemostasis|December 22, 1999
Mechanisms of signaling through urokinase receptor and the cellular responseY Koshelnick, M Ehart, H Stockinger, et al.
Blood|July 6, 2000
In vivo inhibition of low density lipoprotein receptor-related protein improves survival of factor VIII in the absence of von Willebrand factorP L Turecek, H P Schwarz, B R Binder
Thrombosis Research|September 1, 1994
Fibrinolytic system of cultured rabbit aortic endothelial cellsD B al-Azhary, J Wojta, B R Binder
European Urology|January 1, 1984
Tissue plasminogen activator activity in prostatic cancerA Köller, J Kirchheimer, H Pflüger, et al.
Immunopharmacology|June 1, 1997
Protein C inhibitor (PCI) and heparin cofactor II (HCII): possible alternative roles of these heparin-binding serpins outside the hemostatic systemM Geiger, M Krebs, I Jerabek, et al.
Pageof 22